Table 3.
The frequency of E.bieneusi in the participants based on gender
| P-value | Total |
E.bieneusi
|
Sex | Subjects | |
|---|---|---|---|---|---|
|
Positive
N (%) |
Negative
N (%) |
||||
| 0.471 | 36(100) | 0(0) | 36(100) | Female | Immunocompetent |
| 32(100) | 1(3.1) | 31(96.9) | Male | ||
| 68(100) | 1(1.5) | 67(98.5) | Total | ||
| 0.999 | 21(100) | 3(14.3) | 18(85.7) | Female | Cancer-positive |
| 38(100) | 6(15.8) | 32(84.2) | Male | ||
| 59(100) | 9(15.3) | 50(84.7) | Total | ||
| 0.998 | 26(100) | 4(15.4) | 22(84.6) | Female | HIV/AIDS-positive |
| 46(100) | 6(13) | 40(87) | Male | ||
| 72(100) | 10(13.9) | 62(86.1) | Total | ||
Significant difference at P<0.05